StockData
Northwest Biotherapeutics Inc logo

Northwest Biotherapeutics Inc (NWBO) stock

NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)

Close on Oct 19, 2026Market cap $254.79MP/E –Yield –

Northwest Biotherapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

No price to book ratio figures for Northwest Biotherapeutics

Northwest Biotherapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Northwest Biotherapeutics figures

See a number that looks wrong?